Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans

被引：84

作者：

Uhl, Franziska M. ^{[1
,2
]}

Chen, Sophia ^{[1
,3
]}

O'Sullivan, David ^{[4
]}

Edwards-Hicks, Joy ^{[4
]}

Richter, Gesa ^{[5
]}

Haring, Eileen ^{[1
,2
]}

Andrieux, Geoffroy ^{[6
,7
,8
]}

Halbach, Sebastian ^{[9
]}

Apostolova, Petya ^{[1
,4
]}

Buscher, Jorg ^{[4
]}

Duquesne, Sandra ^{[1
]}

Melchinger, Wolfgang ^{[1
]}

Sauer, Barbara ^{[1
]}

Shoumariyeh, Khalid ^{[1
]}

Schmitt-Graeff, Annette ^{[10
]}

Kreutz, Marina ^{[11
,12
]}

Lubbert, Michael ^{[1
]}

Duyster, Justus ^{[1
]}

Brummer, Tilman ^{[7
,8
,9
]}

Boerries, Melanie ^{[6
,7
,8
]}

Madl, Tobias ^{[5
,13
]}

Blazar, Bruce R. ^{[14
]}

Gross, Olaf ^{[15
,16
,17
]}

Pearce, Erika L. ^{[4
]}

Zeiser, Robert ^{[1
,16
,17
]}

机构：

[1] Univ Freiburg, Fac Med, Med Ctr, Dept Internal Med 1, D-79106 Freiburg, Germany

[2] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany

[3] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Immunol, New York, NY 10065 USA

[4] Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, D-79108 Freiburg, Germany

[5] Med Univ Graz, Gottfried Schatz Res Ctr Cell Signaling Metab & A, Mol Biol & Biochem, A-8010 Graz, Austria

[6] Univ Freiburg, Fac Med, Med Ctr, Inst Med Bioinformat & Syst Med, D-79110 Freiburg, Germany

[7] German Canc Consortium DKTK, Partner Site Freiburg, D-69120 Heidelberg, Germany

[8] German Canc Res Ctr, D-69120 Heidelberg, Germany

[9] Univ Freiburg, Fac Med, Inst Mol Med & Cell Res IMMZ, D-79104 Freiburg, Germany

[10] Univ Freiburg, D-79085 Freiburg, Germany

[11] Univ Hosp Regensburg, Internal Med 3, D-93042 Regensburg, Germany

[12] Regensburg Ctr Intervent Immunol RCI, D-93053 Regensburg, Germany

[13] BioTechMed Graz, A-8010 Graz, Austria

[14] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA

[15] Univ Freiburg, Fac Med, Med Ctr, Inst Neuropathol, D-79106 Freiburg, Germany

[16] Univ Freiburg, Signalling Res Ctr BIOSS, D-79106 Freiburg, Germany

[17] Univ Freiburg, CIBSS Ctr Integrat Biol Signalling Studies, D-79106 Freiburg, Germany

来源：

SCIENCE TRANSLATIONAL MEDICINE | 2020年 / 12卷 / 567期

基金：

欧洲研究理事会;

关键词：

ACUTE MYELOID-LEUKEMIA; HOST-DISEASE; RELAPSE; TRANSPLANTATION; SURVIVAL; INFUSIONS; THERAPY; IMPACT; PH;

D O I：

10.1126/scitranslmed.abb8969

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Acute myeloid leukemia (AML) relapse after allogeneic hematopoietic cell transplantation (allo-HCT) has a dismal prognosis. We found that T cells of patients relapsing with AML after allo-HCT exhibited reduced glycolysis and interferon-gamma production. Functional studies in multiple mouse models of leukemia showed that leukemia-derived lactic acid (LA) interfered with T cell glycolysis and proliferation. Mechanistically, LA reduced intracellular pH in T cells, led to lower transcription of glycolysis-related enzymes, and decreased activity of essential metabolic pathways. Metabolic reprogramming by sodium bicarbonate (NaBi) reversed the LA-induced low intracellular pH, restored metabolite concentrations, led to incorporation of LA into the tricarboxylic acid cycle as an additional energy source, and enhanced graft-versus-leukemia activity of murine and human T cells. NaBi treatment of post-allo-HCT patients with relapsed AML improved metabolic fitness and interferon-y production in T cells. Overall, we show that metabolic reprogramming of donor T cells is a pharmacological strategy for patients with relapsed AML after allo-HCT.

引用

页数：14

共 50 条

[41] Clinical-Grade-Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell-Dependent Graft-versus-Leukemia Effect in Murine Models
Del Papa, Beatrice
Ruggeri, Loredana
Urbani, Elena
Baldoni, Stefano
Cecchini, Debora
Zei, Tiziana
Ostini, Roberta Iacucci
Crescenzi, Barbara
Carotti, Alessandra
Pierini, Antonio
Sportoletti, Paolo
Di Bartolomeo, Paolo
Falzetti, Franca
Mecucci, Cristina
Velardi, Andrea
Martelli, Massimo F.
Di Ianni, Mauro
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (11) : 1847 - 1851
[42] IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity
Lu, Ying
Giver, Cynthia R.
Sharma, Akshay
Li, Jian Ming
Darlak, Katarzyna A.
Owens, Lauren M.
Roback, John D.
Galipeau, Jacques
Waller, Edmund K.
BLOOD, 2012, 119 (04) : 1075 - 1085
[43] Superior Graft-versus-Leukemia Effect Associated with Transplantation of Haploidentical Compared with HLA-Identical Sibling Donor Grafts for High-Risk Acute Leukemia: An Historic Comparison
Wang, Yu
Liu, Dai-Hong
Xu, Lan-Ping
Liu, Kai-Yan
Chen, Huan
Chen, Yu-Hong
Han, Wei
Shi, Hong-Xia
Huang, Xiao-Jun
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (06) : 821 - 830
[44] ATGS-Dependent Autophagy Uncouples T-cell Proliferative and Effector Functions and Separates Graft-versus-Host Disease from Graft-versus-Leukemia
Oravecz-Wilson, Katherine
Rossi, Corinne
Zajac, Cynthia
Sun, Yaping
Li, Lu
Decoville, Thomas
Fujiwara, Hideaki
Kim, Stephanie
Peltier, Daniel
Reddy, Pavan
CANCER RESEARCH, 2021, 81 (04) : 1063 - 1075
[45] Donor Killer Cell Immunoglobulin-Like Receptor Genotype Does Not Improve Graft-versus-Leukemia Responses in Chronic Lymphocytic Leukemia after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis
Bachanova, Veronika
Weisdorf, Daniel J.
Wang, Tao
Marsh, Steven G. E.
Cereb, Nezih
Haagenson, Michael D.
Spellman, Stephen R.
Lee, Stephanie J.
Guethlein, Lisbeth A.
Parham, Peter
Miller, Jeffrey S.
Cooley, Sarah A.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (05) : 949 - 954
[46] Long-Lasting Graft-Derived Donor T Cells Contribute to the pathogenesis of Chronic Graft-versus-Host Disease in Mice
Kosugi-Kanaya, Mizuha
Ueha, Satoshi
Abe, Jun
Shichino, Shigeyuki
Shand, Francis H. W.
Morikawa, Teppei
Kurachi, Makoto
Shono, Yusuke
Sudo, Naoto
Yamashita, Ai
Suenaga, Fumiko
Yokoyama, Akihiro
Yong, Wang
Imamura, Masahiro
Teshima, Takanori
Matsushima, Kouji
FRONTIERS IN IMMUNOLOGY, 2017, 8
[47] Treg-protected donor lymphocyte infusions: a new tool to address the graft-versus-leukemia effect in the absence of graft-versus-host disease in patients relapsed after HSCT
Di Ianni, Mauro
Olioso, Paola
Giancola, Raffaella
Santarone, Stella
Natale, Annalisa
Papalinetti, Gabriele
Villanova, Ida
Baldoni, Stefano
Di Tommaso, Ambra
Bonfini, Tiziana
Accorsi, Patrizia
Di Bartolomeo, Paolo
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (06) : 860 - 864
[48] Donor origin CAR T cells: graft versus malignancy effect without GVHD, a systematic review
Anwer, Faiz
Shaukat, Al-Aman
Zahid, Umar
Husnain, Muhammad
McBride, Ali
Persky, Daniel
Lim, Melissa
Hasan, Nida
Bin Riaz, Irbaz
IMMUNOTHERAPY, 2017, 9 (02) : 123 - 130
[49] Genetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers
Ghosh, Arnab
Holland, Amanda M.
van den Brink, Marcel R. M.
IMMUNOLOGICAL REVIEWS, 2014, 257 (01) : 226 - 236
[50] Selective Depletion of Alloreactive Donor T Cells Leads to Elimination of Graft-Versus-Host Reactivity and Stimulates Graft-Versus-Leukaemia/Myeloma Effect
Matejkova, E.
Foltankova, V.
Buresova, I.
FOLIA BIOLOGICA, 2013, 59 (04) : 146 - 153

← 1 2 3 4 5 →